Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New England Cryogenic Center (NECC) is a pioneer in the processing and cryopreservation of human cells and tissue, founded in 1971 and headquartered in Marlborough, Massachusetts. The company provides a comprehensive suite of fertility services, including sperm banking, egg and embryo storage, and donor programs, alongside specialized cryogenic transport. NECC also operates as a central repository for the medical and research communities, offering long-term storage for stem cells, bone marrow, and other critical biological materials. As a family-owned enterprise, it manages several specialized subsidiaries such as the New England Cord Blood Bank and the National Dental Pulp Laboratory. The company maintains an FDA-registered facility and adheres to rigorous industry standards to support families and healthcare providers globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New England Cryogenic Center.